Whether a microglial functional shift from CD68high to L-ferritinhigh is a consistent feature across ALS genotypes will determine the breath of utility of microglial-targeting therapies developed in TDP-43 models. Here, TARDBP is linked to amyotrophic lateral sclerosis.